These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5497409)

  • 1. Parachlorophenylalanine treatment in carcinoid syndrome.
    Shani M; Sheba C
    Br Med J; 1970 Dec; 4(5738):784-5. PubMed ID: 5497409
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothermia in a patient with carcinoid syndrome during treatment with parachlorophenylalanine.
    Vaidya AB; Levine RJ
    N Engl J Med; 1971 Feb; 284(5):255-7. PubMed ID: 5539348
    [No Abstract]   [Full Text] [Related]  

  • 3. Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension.
    Kasi PM
    Pancreas; 2018 Jan; 47(1):e2. PubMed ID: 29232344
    [No Abstract]   [Full Text] [Related]  

  • 4. Telotristat ethyl (Xermelo) for carcinoid syndrome diarrhea.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):119-120. PubMed ID: 28699933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological and therapeutical (p-chlorphenylalanine) studies on the carcinoid syndrome].
    von Studnitz W; Waldenström J
    Verh Dtsch Ges Inn Med; 1971; 77():1322. PubMed ID: 5156018
    [No Abstract]   [Full Text] [Related]  

  • 6. The carcinoid syndrome: serotonin and mental function.
    Nahum LH
    Conn Med; 1968 Apr; 32(4):255-7. PubMed ID: 5653061
    [No Abstract]   [Full Text] [Related]  

  • 7. Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues.
    Kasi PM
    Drugs Today (Barc); 2018 Jul; 54(7):423-432. PubMed ID: 30090879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the management of patients with carcinoid syndrome.
    Kulke MH
    Clin Adv Hematol Oncol; 2017 Apr; 15(4):257-259. PubMed ID: 28591101
    [No Abstract]   [Full Text] [Related]  

  • 9. The carcinoid syndrome: chronic treatment with para-chlorophenylalanine.
    Satterlee WG; Serpick A; Bianchine JR
    Ann Intern Med; 1970 Jun; 72(6):919-21. PubMed ID: 5448751
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical aspects of indolealkylamine metabolism. Introductory remarks.
    Sjoerdsma A
    Adv Pharmacol (1962); 1968; 6(Pt B):123-5. PubMed ID: 5688650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological and therapeutic studies (p-chlorphenylalanin) on carcinoid syndrome in 11 cases].
    von Studnitz W; Waldenström J
    Klin Wochenschr; 1971 Jul; 49(13):748-55. PubMed ID: 4254559
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parachlorophenylalanine and ultrastructure in the carcinoid syndrome].
    Rapado A; Oliva H; Traba ML; Díaz Recasens J; Ríuz F; Pérez-Corral F; Farré J; De la Barreda P
    Rev Clin Esp; 1974 Jan; 132(1):11-20. PubMed ID: 4276185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of intestinal carcinoidosis].
    Grossi F; Grassi M
    Clin Ter; 1969 Sep; 50(5):475-80. PubMed ID: 4392675
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of the carcinoid syndrome.
    Lancet; 1968 Feb; 1(7539):404-5. PubMed ID: 4169981
    [No Abstract]   [Full Text] [Related]  

  • 15. Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea.
    Lyseng-Williamson KA
    Drugs; 2018 Jun; 78(9):941-950. PubMed ID: 29931594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome.
    Bax ND; Boulton AJ; Woods HF; Green AR
    Postgrad Med J; 1982 Aug; 58(682):493-5. PubMed ID: 6215640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
    Kulke MH; Hörsch D; Caplin ME; Anthony LB; Bergsland E; Öberg K; Welin S; Warner RR; Lombard-Bohas C; Kunz PL; Grande E; Valle JW; Fleming D; Lapuerta P; Banks P; Jackson S; Zambrowicz B; Sands AT; Pavel M
    J Clin Oncol; 2017 Jan; 35(1):14-23. PubMed ID: 27918724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress report: the carcinoid syndrome.
    Grahame-Smith DG
    Gut; 1970 Feb; 11(2):189-92. PubMed ID: 4913426
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of phenylalanine hydroxylation during treatment of carcinoid syndrome with p-chlorophenylalanine.
    Szeinberg A; Shani M; Crispin M; Hirshorn N; Cohen BE; Sheba C
    Isr J Med Sci; 1970; 6(4):475-8. PubMed ID: 5472331
    [No Abstract]   [Full Text] [Related]  

  • 20. Telotristat ethyl: a new option for the management of carcinoid syndrome.
    Lamarca A; Barriuso J; McNamara MG; Hubner RA; Valle JW
    Expert Opin Pharmacother; 2016 Dec; 17(18):2487-2498. PubMed ID: 27817224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.